QINGFENG Pharma Group, founded in 1976, is an innovation driven and comprehensive pharmaceutical group covering the whole industrial layout including R&D, clinical translation, manufacture and commercialization.
Up to 35 commercialized products with annual sales around 5 billion, we ranked round top 30 pharmaceutical group in China.
Currently we have 2000+ staff, of which 700 + are R&D scientists.
With more than 10% of revenue invested in R&D per year, we have established multiple R&D platforms located in Beijing, Shanghai, Hangzhou and etc., and 60+ pipelines are under development, 35 pipelines to be launched in 2023.
We have three manufacture plants，With a total investment of more than 5 billion RMB, which covers an area of more than 700 acres，with an annual production capacity of 30 tons of APIs , 10 billion tablets, 1 billion capsules, 500 million sterile injections, 300 million oral liquids and 500 million bags of granules.
Our sales network covers 31 provinces, 2000+ counties, 4000+ towns, 5000+ hospitals, 20,000+ clinics and 60,000+ pharmacies.
With our strong above-mentioned and marketing, IP, regulatory, medical and clinical expertise, resources and experience, we are expanding into global market with the focus on oncology, respiratory, anti-infection and CNS areas.